The Design Driver for Biosimilar Adoption
Covering all aspects of biopharmaceutical development, analysis, processing, and packaging, BioPharm International, launched in 1988, provides technical and business insight for all biologic-based therapies. As well as covering business strategies and regulatory issues, the print and digital editorial coverage reaches professionals involved in the development and manufacturing of biopharmaceutical therapeutics and diagnostics.
A recent report estimates, that with a substantial increase in the global market opportunity for manufacturers of biosimilars, it is now valued at $3.12 billion per year. Owen Mumford Pharmaceutical Services’ George I’ons, Head of Product Strategy and Insights, discusses the impact of this alongside the crucial consideration of device design.